Skip to main content
. 2022 Jan 28;11:842169. doi: 10.3389/fonc.2021.842169

Table 2.

Comparison of IVIM-DWI parameters between the control and treated groups at different time points before and after antiangiogenic therapy.

Day 0 Day 1 Day 3 Day 5 Day 7
ADC (×10−3 mm2/s)
Control 0.585 ± 0.112 0.577 ± 0.126 0.487 ± 0.130 0.450 ± 0.150 0.363 ± 0.140
Treated 0.643 ± 0.290 0.668 ± 0.271 0.733 ± 0.182 0.846 ± 0.278 0.968 ± 0.340
p 0.215 0.055 0.033 <0.001 <0.001
D (×10−3 mm2/s)
Control 0.274 ± 0.052 0.268 ± 0.040 0.192 ± 0.087 0.145 ± 0.058 0.086 ± 0.039
Treated 0.288 ± 0.050 0.265 ± 0.064 0.396 ± 0.150 0.499 ± 0.016 0.630 ± 0.290
p 0.730 0.798 0.052 <0.001 <0.001
D* (×10−3 mm2/s)
Control 5.797 ± 1.642 5.946 ± 1.620 7.233 ± 2.760 8.189 ± 2.830 9.061 ± 1.870
Treated 6.374 ± 1.730 5.758 ± 1.450 4.446 ± 1.709 3.475 ± 1.440 3.290 ± 1.102
p 0.505 0.810 0.005 <0.001 <0.001
f (%)
Control 65.833 ± 11.502 59.837 ± 14.230 68.440 ± 22.003 69.164 ± 22.340 80.335 ± 28.037
Treated 69.525 ± 11.320 67.325 ± 12.530 59.355 ± 20.026 55.329 ± 24.703 44.858 ± 14.930
p 0.581 0.368 0.498 0.304 0.008

Comparisons of IVIM-DWI parameters between the control and treated groups at the same time point were performed by the independent-samples t-test.

ADC, apparent diffusion coefficient; D, diffusion coefficient; D*, pseudodiffusion coeffificient; f, perfusion fraction.